Table 1.
Patients' clinical and demographic data.
| Number of patients (%) | |
|---|---|
| N | 90 |
| Mean age (range) | 60 (22–87) |
| ≥60 years | 52 (58%) |
| <60 years | 38 (42%) |
|
| |
| Gender | |
| Male | 68 (75%) |
| Female | 22 (15%) |
|
| |
| Primary site | |
| Oral cavity | 4 (4%) |
| Oropharynx | 49 (55%) |
| Hypopharynx | 10 (10%) |
| Nasopharynx | 13 (15%) |
| Larynx | 14 (16%) |
|
| |
| Clinical T stage | |
| T1 | 15 (17%) |
| T2 | 30 (35%) |
| T3 | 29 (33%) |
| T4 | 13 (15%) |
|
| |
| Clinical N stage | |
| N0 | 5 (5%) |
| N1 | 21 (24%) |
| N2 | 59 (66%) |
| N3 | 5 (5%) |
|
| |
| Clinical stage | |
| III | 32 (35%) |
| IV | 58 (65%) |
|
| |
| Patient cohort after follow-up (PFS) | |
| NED | 62 (69%) |
| RD | 28 (31%) |
|
| |
| Patient cohort after follow-up (OS) | |
| Alive | 65 (72%) |
| Dead | 25 (28%) |